GenIP seeks to build corporate client base driven by new partnerships

Following a Corporate Update in January, GenIP has secured new customers across corporate and academic markets as the AI analytics firm expands its client base beyond its traditional academic channels.

A Spanish innovation network serving approximately 12,000 businesses has adopted GenIP’s Invention Prioritizer product for portfolio management, while a US intellectual property consultancy has engaged GenIP to support its inventor community.

- Advertisement -

In addition, a UK university has returned after commissioning an initial Invention Evaluator report, commissioning deeper market-focused analysis across its technology portfolio.

The company launched its Innovation Exchange webinar series in January, with the first session on KAUST’s technology transfer operations attracting over 40 organisations across four continents. GenIP hopes this can turn into a revenue-generating activity in the future.

GenIP will participate as a panel member at AUTM’s Annual Meeting in Seattle in February, discussing value propositions for underserved populations at the technology transfer industry’s primary Americas conference. Discussions with academic institutes continue across Europe, Latin America, and the Middle East.

“This update reflects a clear evolution in how organisations are engaging with GenIP. Repeat customers are expanding their use of our products, while new corporate clients are adopting higher-value, portfolio-level solutions as part of their ongoing decision-making processes,” said Melissa Cruz, CEO of GenIP.

- Advertisement -

“With global R&D spending now approaching USD 3 trillion per year, yet fewer than 20% of innovations ultimately reaching the market, research organisations are under increasing pressure to make faster, more disciplined portfolio decisions.

“GenIP is addressing this challenge by embedding structured portfolio prioritisation into core innovation workflows, enabling more efficient capital allocation and accelerating the path from research to commercial outcomes. This is translating into growing international momentum across both academic and corporate markets.”

Latest News

More Articles Like This